Abstract Purpose of Review Ischemic cardiomyopathy refers to systolic left ventricular
dysfunction in the setting of obstructive coronary artery disease and represents the most …

Introduction Myocardial infarction (MI) causes extensive structural and functional damage to
the cardiac tissue due to the significant loss of cardiomyocytes. Early reperfusion is the …

Despite significant advances in the prevention and treatment of heart failure (HF), the
prognosis in patients who have been hospitalised on at least one occasion due to …

Heart failure (HF) is a major epidemic with rising morbidity and mortality rates that encumber
global healthcare systems. While some studies have demonstrated the value of CRP in …

Background Heart failure (HF) is a global leading cause of mortality despite implementation
of guideline directed therapy which warrants a need for novel treatment strategies. Proof-of …

Inflammatory activation during acute ST-elevation myocardial infarction (STEMI) can
contribute to post-infarct heart failure (HF). This study aimed to determine prognostic value of …

Despite the widespread use of early revascularization and drugs to regulate the
neuroendocrine system, the impact of such measures on alleviating the development of …

Introduction Cardiorespiratory fitness (CRF) is now established as a vital sign.
Cardiopulmonary exercise testing (CPX) is the gold-standard approach to assessing CRF …

Acute heart failure (AHF) represents a common clinical scenario that requires prompt
evaluation and therapy and that is characterized by a high risk of mortality or subsequent …

Diabetes is a key independent risk factor in the development of heart failure (HF) and a
strong, adverse prognostic factor in HF patients. HF remains the primary cause of …